1. S&P hitting 5,100 is 'a little bit lofty', Tematica Research CIO says

    S&P hitting 5,100 is 'a little bit lofty', Tematica Research CIO says

    9
  2. Dottor Mike Yeadon, ex Chief Scientist e Vicepresidente Pfizer per la Respiratory & Allergy Research

    Dottor Mike Yeadon, ex Chief Scientist e Vicepresidente Pfizer per la Respiratory & Allergy Research

    11
  3. Fed Going Bigger and Bolder, Here’s What You Should Own: Chris Versace

    Fed Going Bigger and Bolder, Here’s What You Should Own: Chris Versace

    16
  4. Dottor Mike Yeadon, ex Chief Scientist e Vicepresidente Pfizer: Mancano 2 minuti alla mezzanotte

    Dottor Mike Yeadon, ex Chief Scientist e Vicepresidente Pfizer: Mancano 2 minuti alla mezzanotte

    13
    0
    516
    3